Dr. Ellen Kraig's lab focuses on researching how certain drugs, called mTOR inhibitors, can promote healthier aging in older adults. The lab conducts studies to understand how different doses and schedules of these drugs affect the health and biology of elderly individuals. Through careful testing, they aim to determine the safest and most effective ways to use these drugs to improve health outcomes as people age.

Dr. Lily Q Dong's lab focuses on understanding how specific proteins in the body can help to control inflammation and metabolic health, particularly in the context of obesity. The research highlights a protein called ABHD17B that may be key in helping macrophages function properly to reduce inflammation associated with excess body fat. By studying these mechanisms, the lab aims to uncover potential new treatments for metabolic diseases like type 2 diabetes that arise from obesity.

Dr. Qitao Ran's research lab at the University of Texas Health Science Center focuses on Alzheimer's disease, exploring innovative ways to target the Hippo signaling pathway to develop new treatments. This pathway is crucial for regulating cell growth and survival, and its abnormal activation has been linked to neurodegeneration. The lab conducts studies using mouse models to better understand how inhibiting this pathway can improve cognitive function and protect neurons from damage in Alzheimer's disease.